'It's clear to me that OHSU is a special place," says OHSU's President-select, Dr. Danny Jacobs.

Researchers at Oregon Health & Science University are challenging the convention that tetanus and diphtheria vaccine boosters need to be administered every 10 years. Their paper in Clinical Infectious Diseases recommends that the current adult ...

Via a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.

OHSU included in an expanded clinical trial assessing the effectiveness of immunotherapy to treat or slow Parkinson's disease.

Findings have significant implications for opioid conversations between patients and their providers.

$128 million NIH grant provides state-of-the-art electron microscopy technology, training to scientists nationwide.

A machine-learning algorithm can predict long-term brain impact, and may identify early treatment opportunities for children.

One of the most highly cited medical scientists in the world, Mills brings a breadth of research, leadership experience to OHSU.

OHSU has announced that Joe Robertson, M.D., M.B.A., will retire as president after nearly 40 years of service. Dr. Robertson said his decision is motivated by a desire to focus on his health and his family.

OHSU develops the first total artificial heart, designed to be a permanent replacement for a failing human heart.